Dashenlin: Ke Yunfeng elected as Chairman, Ke Guoqiang appointed as General Manager

2026-04-06 19:53:24

Abstract generation in progress

On March 31, Dasanlin issued an announcement stating that on March 30, 2026, the company held its 2026 first extraordinary general meeting of shareholders, which elected the company’s fifth session of the board of directors. The board includes 4 non-independent directors, 3 independent directors, and 1 employee representative director, with a three-year term.

The members of the company’s board of directors include Ke Yunfeng (Chairman), Ke Tuoqi, Tan Qunfei, Ke Zhou (non-independent director), Ke Guoqiang (employee representative director), Liu Guochang, Yang Xiaoqiang, and Gong Kaizong (independent director).

In addition, at the first meeting of the company’s fifth session of the board of directors, the company hired 7 senior executives and 1 securities affairs representative. The General Manager is Ke Guoqiang. The Financial Controller and the Secretary of the Board are Peng Guangzhi, and the Securities Affairs Representative is Chen Guozhen.

(Dasanlin announcement)

(Editor: Yang Yan Lin Chen)

Keywords:

                                                            Medical

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes